Last edition
News about "Interleukin-2"
Diakonos Oncology Phase II Glioblastoma Trial Cleared to Continue After DSMB Safety Review
Independent safety review clears Diakonos Oncology’s Phase II DOC1021 glioblastoma trial to proceed, with no safety concerns identified to date.
Interleukin-2 | 18/02/2026 | By News Bureau | 157
GRIT and Quangang to Boost Localization of Interleukin-2
Shanghai Grit Biotechnology Co., Ltd. (GRIT) has forged a formal strategic partnership with Shandong Quangang Pharmaceutical Co., Ltd. (Quangang) to leverage both parties' R&D capabilities in innovative T-cell therapy.
Interleukin-2 | 01/06/2024 | By Aishwarya | 456
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy